BPC-157 Protocol Guide: Dosage, Cycle Length, Injection Sites & Stacking (2026)
For educational purposes only. This content is not medical advice and does not diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any peptide protocol.
BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids derived from a naturally occurring protective protein found in human gastric juice. It has become one of the most widely researched and discussed peptides in the optimization community, with over 100 published studies examining its effects on tissue repair, gut health, and systemic protective mechanisms.
BPC-157 is the single most popular peptide compound tracked in the DoseCraft community, used in over 40% of all logged protocols. This guide compiles clinical research, expert practitioner protocols, and community data to give you the most thorough BPC-157 resource available.
For quick dosing calculations, use the DoseCraft BPC-157 Calculator.
What Is BPC-157? Mechanism of Action
BPC-157 is a pentadecapeptide — a chain of 15 amino acids — with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is a fragment of BPC (Body Protection Compound), a protein isolated from human gastric juice that demonstrates protective effects across multiple organ systems in research models.
Key Research Findings (Evidence Tier: Clinical)
Published studies have demonstrated BPC-157's effects in several areas:
Angiogenesis promotion: BPC-157 upregulates growth factor expression, particularly VEGF (vascular endothelial growth factor), promoting the formation of new blood vessels at injury sites. This accelerates the delivery of nutrients and immune cells to damaged tissue.
Nitric oxide system modulation: BPC-157 interacts with the nitric oxide (NO) system, which plays a central role in blood flow regulation, inflammation modulation, and tissue repair signaling.
Growth hormone receptor interaction: Research indicates BPC-157 may influence the growth hormone receptor pathway, potentially amplifying the body's own repair mechanisms.
Gut-brain axis effects: BPC-157 has demonstrated protective effects on both the GI tract and the central nervous system in animal models, suggesting systemic signaling rather than purely local effects.
Tendon and ligament repair: Multiple animal studies show accelerated healing of transected tendons, with increased collagen organization and mechanical strength.
Citation-ready: According to peer-reviewed research published in the Journal of Physiology-Paris, BPC-157 promotes angiogenesis and accelerates tendon healing through upregulation of growth factor expression and nitric oxide system modulation.
BPC-157 Dosage Guide
Standard Dosing Range
| Protocol Level | Dose per Injection | Frequency | Evidence Tier |
|---|---|---|---|
| Conservative | 200-250 mcg | 1-2x daily | Expert |
| Standard | 250-500 mcg | 1-2x daily | Expert |
| Aggressive | 500-750 mcg | 1-2x daily | Experimental |
Weight-Based Dosing
Clinical research in animal models typically uses doses in the range of 10 mcg/kg of body weight. Scaled to human application by leading practitioners:
| Body Weight | Conservative (3 mcg/kg) | Standard (5 mcg/kg) | Upper Range (8 mcg/kg) |
|---|---|---|---|
| 60 kg (132 lbs) | 180 mcg | 300 mcg | 480 mcg |
| 75 kg (165 lbs) | 225 mcg | 375 mcg | 600 mcg |
| 90 kg (198 lbs) | 270 mcg | 450 mcg | 720 mcg |
| 100 kg (220 lbs) | 300 mcg | 500 mcg | 800 mcg |
Most clinical experts recommend starting at 250 mcg twice daily (500 mcg total daily dose) for the average adult. This dosing range appears most frequently in practitioner protocols and community logs.
Use the DoseCraft Calculator to determine your exact syringe volume based on reconstitution.
Twice-Daily Dosing Rationale
BPC-157 has an estimated half-life of approximately 4 hours. Splitting the daily dose into two injections (morning and evening) maintains more stable blood levels throughout the day. This approach is endorsed by the majority of experienced practitioners.
Route of Administration: Injectable Only
Leading practitioners are unequivocal: BPC-157 must be administered via subcutaneous (SubQ) injection for effective systemic results. Oral administration is rendered ineffective by proteolytic enzymes in the digestive system and first-pass liver metabolism.
Why Oral BPC-157 Does Not Work for Systemic Effects
Despite marketing claims about "gastric stability," oral BPC-157 faces multiple barriers:
- Proteolytic degradation: Pepsin, trypsin, and chymotrypsin in the digestive tract break peptide bonds on contact
- First-pass liver metabolism: Any surviving peptide fragments are metabolized by the liver before reaching systemic circulation
- Bioavailability: Effectively near 0% for systemic targets (tendons, joints, nerves, brain)
Companies selling oral BPC-157 capsules often cite the peptide's origin in gastric juice as evidence of oral viability. This is a half-truth: surviving stomach acid is not the same as surviving enzymatic degradation, crossing the intestinal epithelium, and reaching therapeutic concentrations in systemic circulation.
The published studies demonstrating BPC-157's systemic effects — tendon repair, neuroprotection, cardiovascular protection, anti-inflammatory activity — all used injectable routes (subcutaneous or intraperitoneal). Not oral.
Injectable BPC-157
- Bioavailability: Near 100% (subcutaneous)
- Best for: Localized injuries, musculoskeletal issues, systemic protocols, gut healing
- Onset: Effects may be noticed within days to 1-2 weeks
- Evidence tier: Clinical + Expert
- Route: Subcutaneous injection near injury site for local effects, or abdominal SubQ for systemic effects
How to Administer BPC-157: Injection Protocol
Step 1: Reconstitute the Vial
Add 2 mL of bacteriostatic water to a 5 mg BPC-157 vial. Direct the water stream against the glass wall — never directly onto the lyophilized powder. Allow the powder to dissolve naturally without shaking. The solution should be clear and colorless.
Step 2: Calculate Your Dose
With 5 mg in 2 mL, concentration = 2,500 mcg/mL. For a 250 mcg dose: 250 / 2,500 = 0.1 mL = 10 units on a 100-unit insulin syringe.
Step 3: Select Your Injection Site
- For localized injury: Inject subcutaneously as close to the injury site as possible. BPC-157 promotes local angiogenesis, so proximity to the target tissue may enhance results.
- For systemic protocols: Inject subcutaneously in the lower abdomen (fat pad), rotating sites.
- For gut protocols: Abdominal subcutaneous injection.
Step 4: Inject
Clean the injection site with an alcohol swab. Pinch the skin, insert the needle at a 45-degree angle, inject slowly, and withdraw. Apply gentle pressure with a clean swab.
Step 5: Store Properly
Reconstituted BPC-157 should be stored in the refrigerator (36-46degF / 2-8degC). Use within 28-30 days of reconstitution. Never freeze reconstituted peptides.
For a visual syringe guide and automatic dose calculation, try the DoseCraft Calculator.
BPC-157 Injection Sites
Injection site selection depends on protocol goals:
| Goal | Recommended Injection Site | Rationale |
|---|---|---|
| Shoulder injury | Subcutaneous near deltoid | Local angiogenesis at injury site |
| Knee injury | Subcutaneous around patella | Direct proximity to damaged tissue |
| Elbow/tendon | Subcutaneous near affected tendon | Collagen synthesis at target |
| Gut healing | Lower abdomen SubQ | Proximity to GI tract |
| General systemic | Lower abdominal fat pad | Consistent absorption, easy rotation |
| Post-surgical | Around surgical site (after closure) | Accelerated wound healing support |
Rotate injection sites within the target area to prevent lipodystrophy (changes in fat tissue from repeated injections in the same spot).
BPC-157 Cycle Length
Standard Cycle
| Phase | Duration | Notes |
|---|---|---|
| Active phase | 4-8 weeks | Most protocols run 4-6 weeks |
| Off period | 2-4 weeks | Allows receptor resensitization |
| Second cycle | 4-8 weeks | If needed for ongoing support |
Cycle Recommendations by Goal
- Acute injury: 4-6 weeks at standard dose, reassess
- Chronic tendon issue: 6-8 weeks, may repeat after 4-week break
- Gut healing: 4-8 weeks injectable (abdominal SubQ)
- General optimization: 4 weeks on, 4 weeks off
Leading practitioners emphasize that BPC-157 does not appear to cause dependency or tolerance in published research, but cycling remains best practice to maintain receptor sensitivity.
BPC-157 Stacking Options
BPC-157 is frequently combined with other peptides for synergistic effects. The most common stacks include:
BPC-157 + TB-500 (Healing Stack)
This is the most popular peptide stack worldwide. BPC-157 and TB-500 operate through complementary mechanisms:
- BPC-157: Promotes angiogenesis and local tissue repair
- TB-500: Upregulates actin, promoting cell migration and systemic healing
| Compound | Dose | Frequency |
|---|---|---|
| BPC-157 | 250-500 mcg | 2x daily |
| TB-500 | 750 mcg-2 mg | 2x weekly (loading), 1x weekly (maintenance) |
Evidence tier: Expert (practitioner-endorsed)
BPC-157 + GHK-Cu (Tissue Regeneration Stack)
- BPC-157: Tissue repair and angiogenesis
- GHK-Cu: Copper peptide promoting collagen synthesis and antioxidant activity
Evidence tier: Experimental
BPC-157 + KPV (Gut Healing Stack)
- BPC-157: Gastric protection and gut repair
- KPV: Anti-inflammatory tripeptide targeting gut inflammation
Evidence tier: Experimental
Explore all stacking options in the DoseCraft Stacking Guide.
Potential Side Effects and Safety Considerations
Reported Side Effects (from community data and clinical literature)
- Injection site redness/irritation: Common, typically resolves within hours
- Mild nausea: Occasional, typically transient
- Lightheadedness: Rare, may relate to nitric oxide modulation
- Fatigue: Uncommon, usually temporary
Safety Profile
BPC-157 has demonstrated a remarkably clean safety profile in published research. In animal studies using doses far exceeding typical human protocols, no organ toxicity or serious adverse effects were reported.
However, BPC-157 has not undergone formal Phase III human clinical trials. All human usage is based on preclinical research and practitioner experience.
Contraindications and Cautions
- Active cancer or history of cancer: BPC-157 promotes angiogenesis, which could theoretically support tumor blood supply. Consult an oncologist before use.
- Pregnancy and breastfeeding: No safety data available. Avoid use.
- Medications: If taking anticoagulants or blood pressure medication, discuss with a healthcare provider, as BPC-157 may influence nitric oxide pathways.
BPC-157 Research Summary
| Study Area | Findings | Species | Evidence Tier |
|---|---|---|---|
| Tendon healing | Accelerated repair, increased collagen | Rat | Clinical |
| Muscle injury | Faster recovery, reduced inflammation | Rat | Clinical |
| Gut protection | Protection against NSAID-induced damage | Rat | Clinical |
| Bone healing | Enhanced fracture repair | Rat | Clinical |
| Liver protection | Reduced alcohol-induced liver damage | Rat | Clinical |
| Corneal healing | Accelerated corneal injury repair | Rat | Clinical |
| Neuroprotection | Protection in brain injury models | Rat | Clinical |
Important note: The majority of published BPC-157 research has been conducted in animal models. While results are promising and consistent, direct extrapolation to humans requires caution.
Frequently Asked Questions
What is the best BPC-157 dosage for beginners?
Most clinical experts recommend starting with 250 mcg twice daily (500 mcg total daily dose) for the first protocol. This falls within the standard dosing range and allows assessment of individual response before adjusting upward. Use the DoseCraft Calculator to convert this to syringe units based on your reconstitution.
How long does it take for BPC-157 to work?
Based on practitioner reports and community data, many users notice initial effects within 3-7 days for acute injuries. Chronic conditions may require 2-4 weeks before meaningful improvement is observed. A full 4-6 week cycle is recommended for comprehensive assessment.
Should I inject BPC-157 near the injury or in the stomach?
For musculoskeletal injuries, injecting subcutaneously near the injury site is preferred by most practitioners, as BPC-157 promotes local angiogenesis. For gut-related protocols, abdominal subcutaneous injection is recommended. For general systemic support, abdominal subcutaneous injection works well.
Can I take BPC-157 orally?
No. Leading practitioners are clear that BPC-157 must be injected subcutaneously for effective results. Oral administration is rendered ineffective by proteolytic enzymes and first-pass liver metabolism. Companies marketing oral BPC-157 capsules are selling what amounts to expensive amino acids — the peptide chain is destroyed before reaching systemic circulation at therapeutic concentrations.
Is BPC-157 safe?
BPC-157 has demonstrated a clean safety profile across over 100 published animal studies with no reported organ toxicity. However, it has not completed formal human clinical trials. The most commonly reported side effects are minor injection site reactions. Individuals with active cancer, who are pregnant, or on certain medications should consult a healthcare provider before use.
Can I stack BPC-157 with TB-500?
Yes. The BPC-157 + TB-500 combination is the most popular peptide stack, with complementary mechanisms of action. BPC-157 promotes angiogenesis and local repair, while TB-500 upregulates actin for cell migration and systemic healing. See the DoseCraft Stacking Guide for detailed protocols.
How do I store BPC-157?
Lyophilized (powder) BPC-157 should be stored in a cool, dry place — refrigeration extends shelf life. Once reconstituted with bacteriostatic water, store in the refrigerator and use within 28-30 days. Never freeze reconstituted peptides.
How many vials of BPC-157 do I need for a full cycle?
For a standard 4-week cycle at 250 mcg twice daily (500 mcg/day), you need 14,000 mcg (14 mg) total. That is approximately three 5 mg vials. For a 6-week cycle, plan for four 5 mg vials.
Build Your BPC-157 Protocol
Ready to start? The DoseCraft Protocol Builder lets you configure your BPC-157 cycle with automatic dose calculations, scheduling, and progress tracking. Explore the full BPC-157 compound profile in the DoseCraft Library.
For educational purposes only. This content has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before beginning any peptide protocol.